Now that genomes can be sequenced for $1,000, more patients can benefit, says Howard Jacob.
Claims for a new, simple, technique to create stem cells.
New method could help scientists understand neural circuits and tumor biology.
Following the Supreme Court's rejection of gene patents, the U.S. proposes steep cuts to reimbursements for tests that detect breast cancer genes.
Personal genetics company 23andMe will only sell ancestry reports and raw data as controversy with regulators continues.
Physicists have developed a technique that can tell which parts of the brain rely on analog signals and which rely on digital signals.
The U.S. government is concerned that some of 23andMe’s health assessments could mislead customers.
Researchers uncover new ties between genetics and skin cancer by mining patients’ medical records.
High-throughput sequencing takes another step into the clinic with first regulatory approvals.
Three large clinical trials show little benefit to analyzing the genes of patients to find the right dose of blood thinners.